AndrewWild (Talk | contribs) |
|||
(11 intermediate revisions by 5 users not shown) | |||
Line 51: | Line 51: | ||
} | } | ||
} | } | ||
+ | ul{ | ||
+ | list-style-image:none; | ||
+ | } | ||
+ | .container ul{ | ||
+ | padding-top:20px; | ||
+ | padding-right:40px; | ||
+ | padding-left:80px; | ||
+ | font-size:150%; | ||
+ | } | ||
+ | .container ul li { | ||
+ | /* Text color */ | ||
+ | color: #333; | ||
+ | list-style-type: none; | ||
+ | } | ||
+ | |||
+ | .container ul li:before { | ||
+ | /* Unicode bullet symbol */ | ||
+ | content: '\25AA'; | ||
+ | /* Bullet color */ | ||
+ | color: #47BCC2; | ||
+ | padding-right: 0.5em; | ||
+ | } | ||
+ | .container ul ul{ | ||
+ | padding-top:20px; | ||
+ | padding-right:40px; | ||
+ | padding-left:80px; | ||
+ | |||
+ | } | ||
+ | .container ul ul li { | ||
+ | /* Text color */ | ||
+ | color: #333; | ||
+ | list-style-type: none; | ||
+ | } | ||
+ | |||
+ | .container ul ul li:before { | ||
+ | /* Unicode bullet symbol */ | ||
+ | content: '\25AA'; | ||
+ | /* Bullet color */ | ||
+ | color: #47BCC2; | ||
+ | padding-right: 0.5em; | ||
+ | } | ||
+ | ol{ | ||
+ | padding-top:20px; | ||
+ | padding-right:40px; | ||
+ | padding-left:80px; | ||
+ | font-size:150%; | ||
+ | } | ||
+ | ol li { | ||
+ | /* Text color */ | ||
+ | color: #333; | ||
+ | list-style-type: none; | ||
+ | } | ||
+ | ol li { | ||
+ | list-style-type: none; | ||
+ | counter-increment: list; | ||
+ | position: relative; | ||
+ | } | ||
+ | |||
+ | ol li:before { | ||
+ | content: counter(list) "."; | ||
+ | position: absolute; | ||
+ | left: -2.5em; | ||
+ | width: 2em; | ||
+ | text-align: right; | ||
+ | color: #47BCC2; | ||
+ | } | ||
#links{ | #links{ | ||
color:#47BCC2; | color:#47BCC2; | ||
Line 732: | Line 798: | ||
<!--Counter and topnav ends--> | <!--Counter and topnav ends--> | ||
<!--Content begins--> | <!--Content begins--> | ||
+ | <div class="container"> | ||
<h1 >Awards</h1> | <h1 >Awards</h1> | ||
<h2 style="color:#A57164; text-decoration: underline;">Bronze</h2> | <h2 style="color:#A57164; text-decoration: underline;">Bronze</h2> | ||
Line 744: | Line 811: | ||
<h6>Attribution:</h6> | <h6>Attribution:</h6> | ||
<ul> | <ul> | ||
− | <li>We created an "<a href="https://2016.igem.org/Team:Exeter/Attributions">Attributions and | + | <li>We created an "<a href="https://2016.igem.org/Team:Exeter/Attributions">Attributions and Acknowledgements page</a>" for students, |
supervisors and advisors throughout.</li> | supervisors and advisors throughout.</li> | ||
</ul> | </ul> | ||
<h6>Part/Contribution</h6> | <h6>Part/Contribution</h6> | ||
<ul> | <ul> | ||
− | <li>We submitted and further characterised KillerRed (<a href="http://parts.igem.org/Part:BBa_K1914002"> | + | <li>We submitted and further characterised KillerRed (<a href="http://parts.igem.org/Part:BBa_K1914002">BBa_K1914002</a>).</li> |
<br /> | <br /> | ||
− | <li>We submitted KillerOrange phototoxic protein kill switch and provided extensive characterisation (<a href="http://parts.igem.org/Part:BBa_K1914000"> | + | <li>We submitted KillerOrange phototoxic protein kill switch and provided extensive characterisation (<a href="http://parts.igem.org/Part:BBa_K1914000">BBa_K1914000</a>).</li> |
<br /> | <br /> | ||
<li>We designed a codon optimised Lysozyme C Biobrick which targets the enzyme to the periplasm where it is most effective. | <li>We designed a codon optimised Lysozyme C Biobrick which targets the enzyme to the periplasm where it is most effective. | ||
− | (<a href="http://parts.igem.org/Part:BBa_K1914004"> | + | (<a href="http://parts.igem.org/Part:BBa_K1914004">BBa_K1914004</a>)</li>. |
</ul> | </ul> | ||
<h2 style="color:#757575; text-decoration: underline;" >Silver</h2> | <h2 style="color:#757575; text-decoration: underline;" >Silver</h2> | ||
Line 781: | Line 848: | ||
<h6>Human Practices</h6> | <h6>Human Practices</h6> | ||
<ul> | <ul> | ||
− | <li>We performed research on <a href="https://2016.igem.org/Team:Exeter/Integrated_Practices | + | <li>We performed research on <a href="https://2016.igem.org/Team:Exeter/Integrated_Practices/ED"> |
equality and diversity</a> in science, using the University of Exeter as a case study.</li> | equality and diversity</a> in science, using the University of Exeter as a case study.</li> | ||
<br /><li>We have created and tested an <a href="https://2016.igem.org/Team:Exeter/Engagement#section_1"> | <br /><li>We have created and tested an <a href="https://2016.igem.org/Team:Exeter/Engagement#section_1"> | ||
Line 788: | Line 855: | ||
<br /><li>We have <a href="https://2016.igem.org/Team:Exeter/Engagement">engaged the public</a> | <br /><li>We have <a href="https://2016.igem.org/Team:Exeter/Engagement">engaged the public</a> | ||
with synthetic biology on multiple fronts: | with synthetic biology on multiple fronts: | ||
− | <ul style="font-size: | + | <ul style="font-size:100%;"> |
− | <li><a href="">Desert Island...Science?</a> podcast - interviewing academics, researchers | + | <li><a href="https://2016.igem.org/Team:Exeter/dis">Desert Island...Science?</a> podcast - interviewing academics, researchers |
and public figures about synthetic biology, public engagement, | and public figures about synthetic biology, public engagement, | ||
education and their research. This has been published on Youtube, | education and their research. This has been published on Youtube, | ||
Line 795: | Line 862: | ||
<br /><li>Interviews with prominent academics, like | <br /><li>Interviews with prominent academics, like | ||
<a href="https://2016.igem.org/Team:Exeter/Engagement#section_6">Prof. Richard Dawkins</a> and | <a href="https://2016.igem.org/Team:Exeter/Engagement#section_6">Prof. Richard Dawkins</a> and | ||
− | <a href="https://2016.igem.org/Team:Exeter/Integrated_Practices# | + | <a href="https://2016.igem.org/Team:Exeter/Integrated_Practices/lab#section_2">Prof. Richard |
Titball</a> about their thoughts on public engagement and the importance of Biosafety, | Titball</a> about their thoughts on public engagement and the importance of Biosafety, | ||
respectively.</li> | respectively.</li> | ||
<br /><li>We hosted a panel discussion on equality and diversity at the university creating a two | <br /><li>We hosted a panel discussion on equality and diversity at the university creating a two | ||
− | way conversation with the public on the topic.</a> | + | way conversation with the public on the topic.</a></li> |
− | + | </ul> | |
<br /> | <br /> | ||
<li>We designed a <a href="https://2016.igem.org/Team:Exeter/Engagement#section_2"> | <li>We designed a <a href="https://2016.igem.org/Team:Exeter/Engagement#section_2"> | ||
Line 811: | Line 878: | ||
<h2 style="color:#9C7C38; text-decoration: underline;" >Gold</h2> | <h2 style="color:#9C7C38; text-decoration: underline;" >Gold</h2> | ||
<h6 style="text-align:center;"><a style="color:#9C7C38;" href="https://2016.igem.org/Team:Exeter/HP/Gold">Dedicated human practices gold award page here</a></h6> | <h6 style="text-align:center;"><a style="color:#9C7C38;" href="https://2016.igem.org/Team:Exeter/HP/Gold">Dedicated human practices gold award page here</a></h6> | ||
− | <p id="pp">All of the information below can be found on the <a href=""> | + | <p id="pp">All of the information below can be found on the <a href="https://2016.igem.org/Team:Exeter/Integrated_Practices"> |
Integrated Human Practices page</a></p> | Integrated Human Practices page</a></p> | ||
<ul> | <ul> | ||
<li>The effectiveness of kill switches was discussed with academics and individuals in industry to inform our experiments. We then tested what | <li>The effectiveness of kill switches was discussed with academics and individuals in industry to inform our experiments. We then tested what | ||
was discussed and designed parts to address the major concerns.</li> | was discussed and designed parts to address the major concerns.</li> | ||
− | <br /><li> | + | <br /><li>Integrated: Equality and Diversity - |
− | <ul> | + | <ul style="font-size:100%;"> |
− | <li>We took a different approach to | + | <li>We took a different approach to Integrated Human Practices by integrating the Equality and Diversity work into itself - each interview influenced the next forming a |
grounded analysis of the issue.</li> | grounded analysis of the issue.</li> | ||
− | <br /><li> | + | <br /><li>Whilst not strictly Integrated, our board game; BioMech, embeds the principles of our lab work - biosafety and effective plasmid construction - into a fun |
and engaging educational tool.</li> | and engaging educational tool.</li> | ||
</ul></li> | </ul></li> | ||
− | <br /><li> | + | <br /><li>Equally, we have provided a framework for the implementation of a Synthetic Biology Module at our University in order to provide a better understanding of the field to fill the gap in knowledge we found during our human practices. Assessment is in the style of the iGEM jamboree</li> |
</ul> | </ul> | ||
<h6>Improve a previous part or project:</h6> | <h6>Improve a previous part or project:</h6> | ||
− | <ul> | + | <ul > |
<li>We have further characterised KillerRed by testing it under a wider range of conditions and quantified the length of time for it to remain viable as a kill switch.</li> | <li>We have further characterised KillerRed by testing it under a wider range of conditions and quantified the length of time for it to remain viable as a kill switch.</li> | ||
<br /><li>We have improved Lysozyme C by adding a signal peptide targeting it to the periplasm where it is most effective.</li> | <br /><li>We have improved Lysozyme C by adding a signal peptide targeting it to the periplasm where it is most effective.</li> | ||
Line 832: | Line 899: | ||
<h6>Proof of concept</h6> | <h6>Proof of concept</h6> | ||
<ul> | <ul> | ||
− | <li>We used a <a href="https://2016.igem.org/Team:Exeter/ | + | <li>We used a <a href="https://2016.igem.org/Team:Exeter/Proof" >ministat</a> array to test the longevity of kill switches and to simulate their real world application in an industrial chemostat setting.</li> |
</ul> | </ul> | ||
<h6>Demonstrate your work:</h6> | <h6>Demonstrate your work:</h6> | ||
Line 844: | Line 911: | ||
<br /> | <br /> | ||
− | + | </div> | |
<!--Content Ends--> | <!--Content Ends--> |
Latest revision as of 03:05, 20 October 2016